Health data standardization and real-world evidence
5 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- PFIZER LIMITED
Global pharmaceutical company contributing drug development expertise, clinical data, and regulatory science across 54 H2020 health research partnerships.
“Participant in EHDEN (OMOP/OHDSI data standardization), HARMONY (big data in hematology), DO-IT (big data for outcomes), and ConcePTION (pregnancy pharmacovigilance).”
UK54 projects - SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
Sanofi's R&D division contributing pharma-scale drug safety, oncology, and clinical trial expertise across 37 major EU health partnerships.
“EHDEN builds federated health data networks using OMOP CDM, MOBILISE-D develops digital mobility endpoints, IDEA-FAST identifies digital fatigue endpoints, and DO-IT focuses on big data for health outcomes.”
FR37 projects - H. LUNDBECK AS
Danish pharmaceutical company specialized in brain diseases, contributing drug development expertise to EU neuroscience and Parkinson's research consortia.
“Contributed to EHDEN (OMOP CDM/OHDSI federated data network), ROADMAP (Alzheimer's real-world outcomes platform), and RADAR-CNS (remote digital monitoring).”
DK18 projects - CELGENE MANAGEMENT SARL
Global pharma company contributing oncology expertise, real-world patient data, and drug development knowledge to large European health research consortia.
“Participated in EHDEN (OMOP CDM, FAIR data, federated networks), DO-IT (big data for better outcomes), and HARMONY (big data platform for hematology).”
PrimaryCH6 projects - TRNAVSKA UNIVERZITA V TRNAVE
Slovak university specializing in non-communicable disease prevention, cervical cancer screening with AI, and interdisciplinary health-humanities research.
“unCoVer worked on COVID-19 cohort data standardization; PRESCRIP-TEC applies AI to cervical cancer screening data.”
SK5 projects